BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 35469851)

  • 21. Revealing the suppressive role of protein kinase C delta and p38 mitogen-activated protein kinase (MAPK)/NF-κB axis associates with lenvatinib-inhibited progression in hepatocellular carcinoma in vitro and in vivo.
    Wu CH; Hsu FT; Chao TL; Lee YH; Kuo YC
    Biomed Pharmacother; 2022 Jan; 145():112437. PubMed ID: 34864311
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lenvatinib Synergistically Promotes Radiation Therapy in Hepatocellular Carcinoma by Inhibiting Src/STAT3/NF-κB-Mediated Epithelial-Mesenchymal Transition and Metastasis.
    Weng YS; Chiang IT; Tsai JJ; Liu YC; Hsu FT
    Int J Radiat Oncol Biol Phys; 2023 Mar; 115(3):719-732. PubMed ID: 36245124
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Downregulation of SNAIL sensitizes hepatocellular carcinoma cells to TRAIL-induced apoptosis by regulating the NF-κB pathway.
    Wan Z; Pan H; Liu S; Zhu J; Qi W; Fu K; Zhao T; Liang J
    Oncol Rep; 2015 Mar; 33(3):1560-6. PubMed ID: 25607597
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Overexpression of Tripartite Motif Conaining 55 (TRIM55) Inhibits Migration and Invasion of Hepatocellular Carcinoma (HCC) Cells via Epithelial-Mesenchymal Transition and Matrix Metalloproteinase-2 (MMP2).
    Li X; Huang L; Gao W
    Med Sci Monit; 2019 Jan; 25():771-777. PubMed ID: 30685767
    [TBL] [Abstract][Full Text] [Related]  

  • 25. RUFY3 promotes the progression of hepatocellular carcinoma through activating NF-κB-mediated epithelial-mesenchymal transition.
    Zhang Y; Ni W; Qin L
    Aging (Albany NY); 2021 Sep; 13(17):21283-21293. PubMed ID: 34510031
    [TBL] [Abstract][Full Text] [Related]  

  • 26. IGFBP2 upregulates ZEB1 expression and promotes hepatocellular carcinoma progression through NF-κB signaling pathway.
    Guo Q; Yu DY; Yang ZF; Liu DY; Cao HQ; Liao XW
    Dig Liver Dis; 2020 May; 52(5):573-581. PubMed ID: 31818638
    [TBL] [Abstract][Full Text] [Related]  

  • 27. miR-595 suppresses cell proliferation and metastasis in hepatocellular carcinoma by inhibiting NF-κB signalling pathway.
    Wang H; Jiang F; Liu W; Tian W
    Pathol Res Pract; 2020 Apr; 216(4):152899. PubMed ID: 32107085
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HAX-1 promotes the migration and invasion of hepatocellular carcinoma cells through the induction of epithelial-mesenchymal transition via the NF-κB pathway.
    Hu YL; Feng Y; Ma P; Wang F; Huang H; Guo YB; Li P; Mao QS; Xue WJ
    Exp Cell Res; 2019 Aug; 381(1):66-76. PubMed ID: 31047882
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ShRNA-targeted COMMD7 suppresses hepatocellular carcinoma growth.
    Zheng L; Liang P; Li J; Huang XB; Liu SC; Zhao HZ; Han KQ; Wang Z
    PLoS One; 2012; 7(9):e45412. PubMed ID: 23049798
    [TBL] [Abstract][Full Text] [Related]  

  • 30. TRIM11 Upregulation Contributes to Proliferation, Invasion, and EMT of Hepatocellular Carcinoma Cells.
    Zhang Z; Xu C; Zhang X; Huang L; Zheng C; Chen H; Wang Y; Ju H; Yao Q
    Oncol Res; 2017 May; 25(5):691-699. PubMed ID: 28244856
    [TBL] [Abstract][Full Text] [Related]  

  • 31. NCAPG2 overexpression promotes hepatocellular carcinoma proliferation and metastasis through activating the STAT3 and NF-κB/miR-188-3p pathways.
    Meng F; Zhang S; Song R; Liu Y; Wang J; Liang Y; Wang J; Han J; Song X; Lu Z; Yang G; Pan S; Li X; Liu Y; Zhou F; Wang Y; Cui Y; Zhang B; Ma K; Zhang C; Sun Y; Xin M; Liu L
    EBioMedicine; 2019 Jun; 44():237-249. PubMed ID: 31176678
    [TBL] [Abstract][Full Text] [Related]  

  • 32. URG4/URGCP enhances the angiogenic capacity of human hepatocellular carcinoma cells in vitro via activation of the NF-κB signaling pathway.
    Xing S; Zhang B; Hua R; Tai WC; Zeng Z; Xie B; Huang C; Xue J; Xiong S; Yang J; Liu S; Li H
    BMC Cancer; 2015 May; 15():368. PubMed ID: 25947641
    [TBL] [Abstract][Full Text] [Related]  

  • 33. miR-451 inhibits cell proliferation in human hepatocellular carcinoma through direct suppression of IKK-β.
    Li HP; Zeng XC; Zhang B; Long JT; Zhou B; Tan GS; Zeng WX; Chen W; Yang JY
    Carcinogenesis; 2013 Nov; 34(11):2443-51. PubMed ID: 23740840
    [TBL] [Abstract][Full Text] [Related]  

  • 34. TRIM52 up-regulation in hepatocellular carcinoma cells promotes proliferation, migration and invasion through the ubiquitination of PPM1A.
    Zhang Y; Tao R; Wu SS; Xu CC; Wang JL; Chen J; Yu YS; Tang ZH; Chen XH; Zang GQ
    J Exp Clin Cancer Res; 2018 Jun; 37(1):116. PubMed ID: 29898761
    [TBL] [Abstract][Full Text] [Related]  

  • 35. FBW7 increases chemosensitivity in hepatocellular carcinoma cells through suppression of epithelial-mesenchymal transition.
    Yu J; Zhang W; Gao F; Liu YX; Chen ZY; Cheng LY; Xie SF; Zheng SS
    Hepatobiliary Pancreat Dis Int; 2014 Apr; 13(2):184-91. PubMed ID: 24686546
    [TBL] [Abstract][Full Text] [Related]  

  • 36. PIM2 promotes hepatocellular carcinoma tumorigenesis and progression through activating NF-κB signaling pathway.
    Tang X; Cao T; Zhu Y; Zhang L; Chen J; Liu T; Ming X; Fang S; Yuan YF; Jiang L; Huang JD; Guan XY
    Cell Death Dis; 2020 Jul; 11(7):510. PubMed ID: 32641749
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A20 suppresses hepatocellular carcinoma proliferation and metastasis through inhibition of Twist1 expression.
    Chen H; Hu L; Luo Z; Zhang J; Zhang C; Qiu B; Dong L; Tan Y; Ding J; Tang S; Shen F; Li Z; Wang H
    Mol Cancer; 2015 Nov; 14():186. PubMed ID: 26538215
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Osteopontin promotes a cancer stem cell-like phenotype in hepatocellular carcinoma cells via an integrin-NF-κB-HIF-1α pathway.
    Cao L; Fan X; Jing W; Liang Y; Chen R; Liu Y; Zhu M; Jia R; Wang H; Zhang X; Zhang Y; Zhou X; Zhao J; Guo Y
    Oncotarget; 2015 Mar; 6(9):6627-40. PubMed ID: 25749383
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MicroRNA-127-5p targets the biliverdin reductase B/nuclear factor-κB pathway to suppress cell growth in hepatocellular carcinoma cells.
    Huan L; Bao C; Chen D; Li Y; Lian J; Ding J; Huang S; Liang L; He X
    Cancer Sci; 2016 Mar; 107(3):258-66. PubMed ID: 26708147
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mannose-mediated inhibitory effects of PA-MSHA on invasion and metastasis of hepatocellular carcinoma via EGFR/Akt/IκBβ/NF-κB pathway.
    Li T; Dong ZR; Guo ZY; Wang CH; Zhi XT; Zhou JW; Li DK; Chen ZT; Chen ZQ; Hu SY
    Liver Int; 2015 Apr; 35(4):1416-29. PubMed ID: 25066210
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.